ariMarketing News
Friday, May 30, 2025
Want Traffic?
  • Home
  • Entrepreneurship
  • Marketing
    • Digital Marketing
    • Mobile Marketing
    • Content Marketing
    • B2B Marketing
    • B2C Marketing
    • Email Marketing
    • Video Marketing
  • Social Media
  • SEO
  • AI
  • Graphic Design
  • PR
  • Videos
  • More
    • Sales Conversion
    • Website Development
    • Traffic/Lead Generation
No Result
View All Result
  • Home
  • Entrepreneurship
  • Marketing
    • Digital Marketing
    • Mobile Marketing
    • Content Marketing
    • B2B Marketing
    • B2C Marketing
    • Email Marketing
    • Video Marketing
  • Social Media
  • SEO
  • AI
  • Graphic Design
  • PR
  • Videos
  • More
    • Sales Conversion
    • Website Development
    • Traffic/Lead Generation
No Result
View All Result
ariMarketing News
No Result
View All Result
  • Marketing
  • Social Media
  • SEO
  • Entrepreneurship
  • AI
  • Graphic Design
  • Public Relations
  • Sales Conversion
  • Website Development
  • Traffic/Lead Generation
  • Videos
Home Entrepreneurship

3 Stocks You Won’t Regret Buying in December 2022

December 1, 2022
in Entrepreneurship
109 1
A A
0
21
SHARES
689
VIEWS
Share on FacebookShare on Twitter

The Fed Chairman recently indicated a slower pace of rate increases. However, many analysts still believe the economy will face a mild recession next year. Therefore, it could be wise to invest in quality stocks with solid growth prospects, such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Lifeway Foods (LWAY). Read .

The Federal Reserve’s aggressive rate hikes to curb the persistently high inflation and geopolitical concerns have brought upon a stock market downturn this year. However, the last CPI data showed signs of slowing inflation. Therefore, Fed Chairman Jerome Powell recently indicated that the central bank would raise interest rates at a slower pace.

Analysts expect a 50-basis-point rate increase at the Fed’s December monetary policy meeting. Powell said, “It makes sense to moderate the pace of our rate increases as we approach the level of restraint that will be sufficient to bring inflation down.”

U.S. equities rallied after Powell’s speech, with the S&P 500 index moving above its 200-day moving average for the first time since April 2022. Moreover, the Dow Jones Industrial Average hauled itself from the bear market territory.

David Russell, VP of market intelligence at TradeStation Group, said, “Powell needs to keep talking tough but he gave Wall Street reason for hope.” “Everyone knows rate hikes take time to operate and we’re seeing their effects as the labor market cools” he added.

According to Goldman Sachs Research, the U.S. economy is forecasted to narrowly avoid a recession as inflation cools off and unemployment climbs slightly. The investment bank’s economists believe there is a 35% probability of the U.S. tipping into a recession over the next year. This estimate is below the median of 65% among forecasters in a Wall Street Journal survey.

Amid this backdrop, investors may consider buying fundamentally strong stocks with solid growth prospects, such as AbbVie Inc. (ABBV), Bristol-Myers Squibb Company (BMY), and Lifeway Foods, Inc. (LWAY).

AbbVie Inc. (ABBV)

Biopharmaceutical company ABBV is engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. The company is present in various therapeutic categories like immunology, oncology, aesthetic, neuroscience, and women’s health products.

On October 22, 2022, ABBV acquired DJS Antibodies Ltd., a privately held UK-based biotechnology company involved in discovering and developing antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

“This acquisition will deliver new capabilities to enhance our current antibody research activities, an opportunity to strengthen our immunology portfolio, and provide a strong foothold for expanded research efforts in the dynamic bioscience hub in Oxford, UK,” said Jonathon Sedgwick, Ph.D., ABBV’s VP and Global head of discovery research.

ABBV’s net revenues increased 3.3% year-over-year to $14.81 billion in the third quarter ended September 30, 2022. The company’s operating income increased 6.9% year-over-year to $4.60 billion. Its adjusted after-tax earnings increased 29.1% year-over-year to $6.53 billion. Also, its adjusted EPS came in at $3.66, representing an increase of 29.3% year-over-year.

Analysts expect ABBV’s EPS and revenue for the quarter ending December 31, 2022, to increase 10.8% and 3.1% year-over-year to $3.67 and $15.35 billion, respectively. It has surpassed Street EPS estimates in each of the trailing four quarters. Over the past year, the stock has gained 39.8% to close the last trading session at $161.18.

ABBV’s POWR Ratings reflect solid prospects. The company has an overall rating of A, which translates to a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

It has an A grade for Quality and a B for Growth and Value. It is ranked #5 out of 160 stocks in the Medical -Pharmaceuticals industry. Click here to see the additional ratings of ABBV for Momentum, Stability, and Stability.

Bristol-Myers Squibb Company (BMY)

BMY develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and COVID-19.

On August 17, 2022, BMY announced the completion of the acquisition of Turning Point Therapeutics, Inc. BMY’s Executive VP of Strategy & Business Development, Elizabeth Mily, said, “Turning Point has distinguished itself in the field of precision oncology, and this acquisition will further strengthen our leading oncology franchise.”

BMY’s total in-line products and new product portfolio revenue increased 8% year-over-year to $8.62 billion for the third quarter ended September 30, 2022. The company’s non-GAAP earnings before income taxes increased 0.9% year-over-year to $5.13 billion. Its non-GAAP EPS attributable to BMY increased 3.1% year-over-year to $1.99. Also, its total expenses increased 4.8% year-over-year to $9 billion.

For fiscal 2022, BMY’s EPS is expected to increase 1.4% year-over-year to $7.62. Its revenue for the quarter ending June 30, 2023, is expected to increase 1% year-over-year to $12 billion. It surpassed the consensus EPS estimates in each of the trailing four quarters. Over the past year, the stock has gained 49.7% to close the last trading session at $80.28.

BMY’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.

It is ranked #4 in the same industry. It has an A grade for Value and a B for Stability, Sentiment, and Quality. To see the other ratings of BMY for Growth and Momentum, click here.

Lifeway Foods, Inc. (LWAY)

LWAY produces, markets, and sells probiotic-based products internationally. The company’s primary product is drinkable kefir, a cultured dairy product. The company also provides European-style soft cheeses. The company sells its products under the Lifeway and Fresh Made brand names and under private labels.

Julie Smolyansky, LWAY’s President and CEO, stated, “We have recently gained traction within the convenience channel, and see this as an opportunity to build brand awareness and introduce new consumers to our single-serve products. We look forward to finishing the year strong and preparing for a healthy 2023.”

LWAY’s net sales increased 29.1% year-over-year to $38.14 million in the third quarter ended September 30, 2022. The company’s gross profit increased 8.5% year-over-year to $7.58 million. Its net income increased 104.8% year-over-year to $983K. Also, its EPS came in at $0.06, representing an increase of 100% year-over-year.

Analysts expect LWAY’s EPS and revenue for fiscal 2023 to increase 375% and 5% year-over-year to $0.38 and $152 million, respectively. The stock has gained 45.2% year-to-date to close the last trading session at $6.68.

It’s no surprise that LWAY has an overall rating of A, which equates to a Strong Buy in our POWR Rating system. It has an A grade for Growth and a B for Value, Stability, Sentiment, and Quality. It is ranked #4 out of 49 stocks in the Food Makers industry. Click here to see LWAY’s rating for Momentum as well.


ABBV shares were trading at $161.01 per share on Thursday morning, down $0.17 (-0.11%). Year-to-date, ABBV has gained 23.55%, versus a -12.85% rise in the benchmark S&P 500 index during the same period.


Dipanjan Banchur

Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets.

More…

The post 3 Stocks You Won’t Regret Buying in December 2022 appeared first on StockNews.com

Read the full article here

Tags: Business NewsFinanceStocks

Subscribe to our mailing list to receives daily updates!

We won't spam you

Previous Post

Pepsi brings ‘Pilk’ to the masses with Lindsay Lohan holiday ad

Next Post

New Balance unties Snap’s AR, voice tech to offer gifting advice

Related Posts

Old Navy shows off activewear with Lindsay Lohan in ‘80s-inspired spot
Entrepreneurship

Old Navy shows off activewear with Lindsay Lohan in ‘80s-inspired spot

May 30, 2025
Sprite targets ads around scorching temps for global summer campaign
Entrepreneurship

Sprite targets ads around scorching temps for global summer campaign

May 29, 2025
Marketing to Gen Alpha: How brands can win over the next generation
Entrepreneurship

Marketing to Gen Alpha: How brands can win over the next generation

May 29, 2025
E.l.f. sets sail with viral TikToker Oliver Widger
Entrepreneurship

E.l.f. sets sail with viral TikToker Oliver Widger

May 28, 2025
YouTube spotlights how brands can own cultural moments at ad showcase
Entrepreneurship

YouTube spotlights how brands can own cultural moments at ad showcase

May 15, 2025
Knorr dupes fast food favorites with Martha Stewart in social-first push
Entrepreneurship

Knorr dupes fast food favorites with Martha Stewart in social-first push

May 14, 2025
Leave Comment

Subscribe to our mailing list to receive updates and special offers!

We will NOT span you!

Check your inbox or spam folder to confirm your subscription.

Latest Articles

Kinder Chocolate lets kids’ imaginations run wild in new campaign

Kinder Chocolate lets kids’ imaginations run wild in new campaign

May 30, 2025
Droga departs Accenture Song CEO post at fluid moment for creativity

Droga departs Accenture Song CEO post at fluid moment for creativity

May 28, 2025
Artificial Intelligence in Enterprise Service Management: What to Expect in 2025

Artificial Intelligence in Enterprise Service Management: What to Expect in 2025

May 27, 2025
In a world of tariffs and turmoil, marketing’s insight is a superpower

How tariffs are reshaping long-term strategies for brands and buyers

May 27, 2025
Coke pushes Gen Z to ditch digital noise and embrace summer fun

Coke pushes Gen Z to ditch digital noise and embrace summer fun

May 27, 2025

Latest Marketing and Entrepreneurship news and articles from the most trusted sources, follow us to get the latest news and tips directly to your inbox.


Learn more

Sections

  • Artificial Intelligence
  • B2B Marketing
  • B2C Marketing
  • Content Marketing
  • Digital Marketing
  • Email Marketing
  • Entrepreneurship
  • Graphic Design
  • Mobile Marketing
  • Public Relations
  • Sales Conversion
  • SEO
  • Social Media
  • Traffic/Lead Generation
  • Uncategorized
  • Video Marketing
  • Videos
  • Website Development

Newsletter

Subscribe to our mailing list to receive updates and special offers!

We will NOT span you!

Check your inbox or spam folder to confirm your subscription.

  • Privacy
  • Terms
  • Press Release
  • Advertise
  • Contact

© 2022 ariMarketing - All rights reserved.

No Result
View All Result
  • Home
  • Entrepreneurship
  • Marketing
    • Digital Marketing
    • Mobile Marketing
    • Content Marketing
    • B2B Marketing
    • B2C Marketing
    • Email Marketing
    • Video Marketing
  • Social Media
  • SEO
  • AI
  • Graphic Design
  • PR
  • Videos
  • More
    • Sales Conversion
    • Website Development
    • Traffic/Lead Generation

© 2022 ariMarketing - All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.